- Report
- January 2026
- 188 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- November 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- August 2026
- 288 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- January 2026
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 190 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 195 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 187 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP
- Report
- July 2026
- 160 Pages
Global
From €3713EUR$4,150USD£3,175GBP

The Endocrinology Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market, which focuses on drugs used to treat endocrine and metabolic disorders. These drugs are used to treat a variety of conditions, including diabetes, thyroid disorders, obesity, and growth hormone deficiency. Endocrinology drugs are typically administered orally, intravenously, or subcutaneously. They can also be administered through inhalation or injection.
Endocrinology drugs are typically developed by pharmaceutical companies and are subject to stringent regulatory approval processes. These drugs are often expensive and require ongoing monitoring and management.
Some of the major companies in the Endocrinology Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more